TD-19, an erlotinib derivative, induces epidermal growth factor receptor wild-type nonsmall-cell lung cancer apoptosis through CIP2A-mediated pathway
Journal of Pharmacology and Experimental Therapeutics (2014) - Comments
pubmed: 25187431  doi: 10.1124/jpet.114.215418  issn: 1521-0103  issn: 0022-3565 

Ting-Ting Chao, Cheng-Yi Wang, Chih-Cheng Lai, Yen-Lin Chen, Yi-Ting Tsai, Pao-Tzu Chen, Hen-I Lin, Yuh-Chin T. Huang, Chung-Wai Shiau, Chong-Jen Yu, Kuen-Feng Chen